FX Bosch, J Ribes, M Díaz, R Cléries - Gastroenterology, 2004 - Elsevier Estimates from the year 2000 indicate that liver cancer remains the fifth most
common malignancy in men and the eighth in women worldwide. The number of new
cases is estimated to be 564,000 per year, including 398,000 in men and ... Cited by 422 - Related articles - BL Direct - All 14 versions
HB El-Serag - Gastroenterology, 2004 - Elsevier Hepatocellular carcinoma (HCC) is increasing in frequency in the United States.
The age-adjusted incidence rates have doubled over the past 2 decades. Similar
increases have affected the mortality and hospitalization rates. Although ... Cited by 358 - Related articles - BL Direct - All 14 versions
GL Armstrong, A Wasley, EP Simard, GM … - Annals of Internal Medicine, 2006 - Am Coll Physicians From National Center for Infectious Diseases, Centers for Disease Control and
Prevention, Atlanta, Georgia, and National Center for Health Statistics, Centers
for Disease Control and Prevention, Hyattsville, Maryland. Cited by 354 - Related articles - BL Direct - All 4 versions
FX Bosch, J Ribes, R Cléries, M Díaz - Clinics in liver disease, 2005 - Elsevier Year 2000 estimates of the incidence of cancer indicate that primary liver
cancer remains the fifth most common malignancy in men and the eighth in women.
The number of new cases has been predicted as 564,000, corresponding to ... Cited by 211 - Related articles - All 8 versions
- ►jcojournal.org AX Zhu, LS Blaszkowsky, DP Ryan, JW Clark, … - Journal of Clinical Oncology, 2006 - jcojournal.org PURPOSE: Hepatocellular carcinoma (HCC) is a vascular tumor with poor prognosis.
Given the reported activity of gemcitabine and oxaliplatin (GEMOX) in HCC and
the potential benefits of targeting the vascular endothelial growth factor ... Cited by 157 - Related articles - All 9 versions
- ►bmj.com JA Davila, RO Morgan, Y Shaib, KA McGlynn, … - British Medical Journal, 2005 - gut.bmj.com Methods: We used the Surveillance Epidemiology and End-Results Program
(SEER)-Medicare linked database to identify patients aged 65 years and older
diagnosed with HCC and randomly selected non-cancer controls between 1994 ... Cited by 152 - Related articles - All 9 versions
- ►va.gov [PDF] JA Davila, RO Morgan, Y Shaib, KA McGlynn, … - Gastroenterology, 2004 - Elsevier Background & Aims: A significantincrease in the incidence of hepatocellular
carcinoma (HCC) has been reported in the United States. The risk factors
underlying this increase remain unclear. Methods: By using Surveillance, ... Cited by 140 - Related articles - BL Direct - All 16 versions
SH Caldwell, DM Crespo, HS Kang, AMS Al- … - Gastroenterology, 2004 - Elsevier Epidemiological studies have shown that obesity is a risk factor for
hepatocellular carcinoma. Similar studies further indicate that diabetes is also
a major risk factor. Both obesity and diabetes are frequently associated ... Cited by 138 - Related articles - BL Direct - All 14 versions
MC Yu, JM Yuan - Gastroenterology, 2004 - Elsevier Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are
the most important risk factors for the development of hepatocellular carcinoma
(HCC) in humans. HBV is the primary cause of HCC in high-risk areas ... Cited by 131 - Related articles - BL Direct - All 15 versions
RH Wiesner, RB Freeman, DC Mulligan - Gastroenterology, 2004 - Elsevier Recent reports suggest that selected patients undergoing liver transplantation
for stage 1–2 hepatocellular cancer (HCC) have an excellent long-term survival
and a low incidence of recurrence. In the past, over 45% of HCC patients on ... Cited by 126 - Related articles - BL Direct - All 15 versions
